{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:08:20Z","timestamp":1747109300040,"version":"3.40.5"},"reference-count":15,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropediatrics"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinal muscular atrophy (SMA) is a rare autosomal recessive genetic disease caused by Survival Motor Protein 1 (SMN1) gene mutations. Classically divided into three types, SMA is characterized by hypotonia, weakness, and tongue fasciculation in the first 6 months of life in type 1, inability to walk and limb weakness in type 2, and failure to run with proximal weakness in type 3 SMA. With the advent of newborn screening, treating presymptomatic patients with Onasemnogene abeparvovec (OA) is the treatment of choice in some centers worldwide. The incidence of jaundice is high in this age group, with no recommendation to guide the use of OA in newborns with jaundice. To our knowledge, treating an SMA patient with alloimmune hemolytic disease of the newborn (HDN), a relatively common disease in the newborn period, has never been reported in the past. We report our experience with dosing a presymptomatic child with SMA who had neonatal jaundice and hemolytic anemia due to hemolytic disease of the newborn who tolerated the treatment well. To our knowledge, this is the first case to report the safety of this novel treatment for an SMA patient with alloimmune HDN.<\/jats:p>","DOI":"10.1055\/a-2491-2141","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:12:13Z","timestamp":1734480733000},"page":"200-203","source":"Crossref","is-referenced-by-count":0,"title":["Onasemnogene Abeparvovec is Safe in Hemolytic Disease of the Newborn: A Case Report"],"prefix":"10.1055","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7938-2659","authenticated-orcid":false,"given":"Momen","family":"Almomen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Neuroscience Center, King Fahd Specialist Hospital, Dammam, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"El Doussouki","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology and Stem Cell Transplantation, King Fahd Specialist Hospital, Dammam, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaikhah","family":"Aldossary","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Neuroscience Center, King Fahd Specialist Hospital, Dammam, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasneem","family":"Atawi","sequence":"additional","affiliation":[{"name":"Department of Physiotherapy, King Fahd Specialist Hospital, Dammam, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: a timely review","volume":"68","author":"S J Kolb","year":"2011","journal-title":"Arch Neurol"},{"issue":"19","key":"ref2","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.3390\/ijms241914873","article-title":"Spinal muscular atrophy: an evolving scenario through new perspectives in diagnosis and advances in therapies","volume":"24","author":"I Angilletta","year":"2023","journal-title":"Int J Mol Sci"},{"volume-title":"Spinal muscular atrophy","year":"1993","author":"T W Prior","key":"ref3"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"W D Arnold","year":"2015","journal-title":"Muscle Nerve"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"J R Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1230889","DOI":"10.3389\/fneur.2023.1230889","article-title":"Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment","volume":"14","author":"E Nigro","year":"2023","journal-title":"Front Neurol"},{"issue":"S 01","key":"ref8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/pr.2013.208","article-title":"Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels","volume":"74","author":"V K Bhutani","year":"2013","journal-title":"Pediatr Res"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"M Delaney","year":"2015","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"24","key":"ref10","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1001\/jama.1991.03460240066029","article-title":"Epidemiology of Rh hemolytic disease of the newborn in the United States","volume":"265","author":"G F Ch\u00e1vez","year":"1991","journal-title":"JAMA"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5152\/TurkPediatriArs.2017.2658","article-title":"Hyperbilirubinemia due to minor blood group (anti-E) incompatibility in a newborn: a case report","volume":"52","author":"M \u00d6zcan","year":"2017","journal-title":"Turk Pediatri Ars"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5582\/irdr.2019.01094","article-title":"Minor blood group incompatibility due to blood groups other than Rh(D) leading to hemolytic disease of fetus and newborn: a need for routine antibody screening during pregnancy","volume":"9","author":"A Agrawal","year":"2020","journal-title":"Intractable Rare Dis Res"},{"volume-title":"The MNS blood group","year":"2005","author":"L Dean","key":"ref13"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2020.11.001","article-title":"Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy","volume":"74","author":"D Chand","year":"2021","journal-title":"J Hepatol"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000362812","article-title":"Intrauterine blood transfusion: current indications and associated risks","volume":"36","author":"I TM Lindenburg","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.omtm.2021.02.014","article-title":"Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec","volume":"21","author":"J W Day","year":"2021","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Neuropediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2491-2141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T22:53:05Z","timestamp":1747090385000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2491-2141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":15,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2025,5,12]]},"published-print":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2491-2141","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0174-304X","1439-1899"],"issn-type":[{"type":"print","value":"0174-304X"},{"type":"electronic","value":"1439-1899"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}